2010至2019年世界卫生组织欧洲区域的白喉
该研究基于世界卫生组织/联合国儿童基金会联合报告表,分析2010至2019年欧洲区域白喉病例及百白破疫苗第一剂和第三剂接种覆盖率,重点关注2019年。2010至2019年区域报告451例白喉病例,百白破疫苗第一剂和第三剂覆盖率分别为92-96%和95-97%。2019年48个国家中11国报告52例病例,39国提交地区覆盖率数据,26国所有地区第三剂覆盖率达90%以上,11国有1-40%地区覆盖率低于80%。
要点
- 2010至2019年欧洲区域报告451例白喉病例,第三剂百白破疫苗覆盖率为95-97%。
- 2019年48个国家中11国报告52例病例,26国所有地区第三剂覆盖率达90%以上。
- 11国有1-40%地区第三剂覆盖率低于80%,需实现所有地区高覆盖并实施推荐加强剂。
核心结论
- 区域层面长期较高的第三剂百白破疫苗覆盖率可能解释了报告白喉病例相对较少。
- 监测系统不完善和实验室诊断能力不足也可能是 contributing factors。
- 观察到的病例仍令人担忧,需在所有地区实现高第三剂覆盖率并实施推荐加强剂以控制白喉和预防暴发。
研究设计与样本
- 数据来源于世界卫生组织/联合国儿童基金会联合报告表,由欧洲区域成员国每年提交。
- 分析2010至2019年白喉病例及百白破疫苗第一剂和第三剂覆盖率,重点关注2019年。
- 2019年分析年龄、疫苗接种状态及各国第一剂和第三剂覆盖率及地区覆盖率数据。
主要发现
- 2010至2019年欧洲区域报告451例白喉病例。
- 百白破疫苗第一剂覆盖率为92-96%,第三剂覆盖率为95-97%。
- 2019年48个提交报告的国家中11国报告52例病例(包括零报告)。
- 39国提交地区第三剂覆盖率数据,其中26国所有地区覆盖率达90%以上,11国有1-40%地区覆盖率低于80%。
临床怎么用
- 作者认为需在所有地区实现高第三剂百白破疫苗覆盖率并实施推荐加强剂以控制白喉和预防暴发。
局限性
- 监测系统不完善和实验室诊断能力不足可能是影响因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundDiphtheria is uncommon in the World Health Organization (WHO) European Region. Nevertheless, sporadic cases, sometimes fatal, continue to be reported.AimTo report on diphtheria cases and coverage with first and third doses of diphtheria, tetanus and pertussis vaccines (DTP1 and DTP3, respectively) for 2010-19 in the Region with a focus on 2019.MethodsData on diphtheria cases were obtained from WHO/United Nations International Children's Emergency Fund (UNICEF) Joint Reporting Forms submitted annually by the Region's Member States. WHO/UNICEF Estimates of National Immunization Coverage for DTP1 and DTP3 were summarised for 2010-19. For 2019, we analysed data on age, and vaccination status and present data by country on DTP1 and DTP3 coverage and the percentage of districts with ≥ 90% and < 80% DTP3 coverage.ResultsFor 2010-19, 451 diphtheria cases were reported in the Region. DTP1 and DTP3 coverage was 92-96% and 95-97%, respectively. For 2019, 52 cases were reported by 11 of 48 countries that submitted reports (including zero reporting). Thirty-nine countries submitted data on percentage of their districts with ≥ 90% and < 80% DTP3 coverage; 26 had ≥ 90% districts with ≥ 90% coverage while 11 had 1-40% districts with < 80% coverage.ConclusionLong-standing high DTP3 coverage at Regional level probably explains the relatively few diphtheria cases reported in the Region. Suboptimal surveillance systems and inadequate laboratory diagnostic capacity may also be contributing factors. Still, the observed cases are of concern. Attaining high DTP3 coverage in all districts and implementing recommended booster doses are necessary to control diphtheria and prevent outbreaks.
引用
- Muscat M, Gebrie B, Efstratiou A, et al. Diphtheria in the WHO European Region, 2010 to 2019. Euro Surveill. 2022. PMID: 35209973. doi:10.2807/1560-7917.ES.2022.27.8.2100058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。